Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs

Cornell Medical Center, New York

Rochester Institute for Digestive Diseases and Sciences, Inc., Rochester

Blair Gastroenterology Associates, Altoona

McGuire VAMC, Richmond

Duke Clinical Research Institute, Durham

University of Florida, Jacksonville

Miami Research Associates, Inc., Miami

Birmingham Gastroenterology Associates, Birmingham

Nashville Medical Research Institute, Nashville

Memphis Gastroenterology Group, Memphis

Gastroenterology Center of the MidSouth, P.C., Germantown

Consultants for Clinical Research, Cincinnati

William Beaumont Hospital, Royal Oak

Saint Louis University, St Louis

IMG Healthcare, LLC, New Orleans

Baylor College of Medicine-VAMC, Houston

Western States Clinical Research, Inc., Wheat Ridge

The Lynn Institute of the Rockies, Colorado Springs

Idaho Gastroenterology Assoc., Boise

Mayo Clinic Hospital, Phoenix

Community Clinical Trials, Orange

Northwest Gastroenterolgy Assoc., Bellevue

Spokane Digestive Disease Center, Spokane

Beth Israel Deconess Medical Center, Boston

FutureCare Studies, Springfield